The Journal of Cell Biology, ISSN 0021-9525, 4/2007, Volume 177, Issue 1, pp. 63 - 72
Steroid receptors regulate gene expression in a ligand-dependent manner by binding specific DNA sequences. Ligand binding also changes the conformation of the...
Ratios | Androgen receptors | Imaging | Cell nucleus | DNA | Cell lines | Fluorescence | Ligands | Pixels | Nuclear interactions | RNA-POLYMERASE-II | DNA-BINDING | COACTIVATOR | ACTIVATION | GLUCOCORTICOID-RECEPTOR | IN-VIVO | TRANSCRIPTION | SITES | LIGAND-BINDING DOMAIN | PROGESTERONE-RECEPTOR | CELL BIOLOGY | Cell Line | Fluorescence Recovery After Photobleaching | Humans | Receptors, Androgen - metabolism | Recombinant Fusion Proteins - analysis | Intracellular Signaling Peptides and Proteins - metabolism | DNA - metabolism | Amino Acid Motifs | Protein Interaction Mapping | Luminescent Proteins - analysis | Receptors, Androgen - analysis | Fluorescence Resonance Energy Transfer | Receptors, Androgen - chemistry | Binding Sites
Ratios | Androgen receptors | Imaging | Cell nucleus | DNA | Cell lines | Fluorescence | Ligands | Pixels | Nuclear interactions | RNA-POLYMERASE-II | DNA-BINDING | COACTIVATOR | ACTIVATION | GLUCOCORTICOID-RECEPTOR | IN-VIVO | TRANSCRIPTION | SITES | LIGAND-BINDING DOMAIN | PROGESTERONE-RECEPTOR | CELL BIOLOGY | Cell Line | Fluorescence Recovery After Photobleaching | Humans | Receptors, Androgen - metabolism | Recombinant Fusion Proteins - analysis | Intracellular Signaling Peptides and Proteins - metabolism | DNA - metabolism | Amino Acid Motifs | Protein Interaction Mapping | Luminescent Proteins - analysis | Receptors, Androgen - analysis | Fluorescence Resonance Energy Transfer | Receptors, Androgen - chemistry | Binding Sites
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2019, Volume 144, Issue 8, pp. 1775 - 1779
The androgen receptor (AR) plays a central role in the pathogenesis of prostate cancer (PCa). Most PCa cases develop eventually from an androgen‐dependent...
receptor degradation | castration resistance | androgen receptor | protein stability | therapy resistance | CELLS | AR-V7 | SPLICE VARIANT | OPEN-LABEL | GANETESPIB | MECHANISMS | CONFERS RESISTANCE | GLUCOCORTICOID-RECEPTOR | ONCOLOGY | INHIBITOR | Receptors, Glucocorticoid - antagonists & inhibitors | Androgen Receptor Antagonists - therapeutic use | Heat-Shock Proteins - metabolism | Humans | Receptors, Androgen - metabolism | Ubiquitin-Protein Ligases - metabolism | Ubiquitin-Protein Ligases - antagonists & inhibitors | Heat-Shock Proteins - antagonists & inhibitors | Male | Antineoplastic Agents - therapeutic use | Receptors, Glucocorticoid - metabolism | Prostatic Neoplasms, Castration-Resistant - drug therapy | Androgen Receptor Antagonists - pharmacology | Prostatic Neoplasms, Castration-Resistant - pathology | Prostate - pathology | Proteolysis - drug effects | Signal Transduction - drug effects | Protein Stability - drug effects | Treatment Failure | Prostate - drug effects | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Drug Resistance, Neoplasm - drug effects | Proteins | Care and treatment | Prostate cancer | Health aspects | Cancer | Therapy | Stability | Glucocorticoids | Therapeutic applications | Pathogenesis | Heat shock proteins | Chaperones | Carcinogenesis | Signaling | Carcinogens | Androgens | Molecular modelling | Castration | Evolution | Prostate | Heat shock | Index Medicus
receptor degradation | castration resistance | androgen receptor | protein stability | therapy resistance | CELLS | AR-V7 | SPLICE VARIANT | OPEN-LABEL | GANETESPIB | MECHANISMS | CONFERS RESISTANCE | GLUCOCORTICOID-RECEPTOR | ONCOLOGY | INHIBITOR | Receptors, Glucocorticoid - antagonists & inhibitors | Androgen Receptor Antagonists - therapeutic use | Heat-Shock Proteins - metabolism | Humans | Receptors, Androgen - metabolism | Ubiquitin-Protein Ligases - metabolism | Ubiquitin-Protein Ligases - antagonists & inhibitors | Heat-Shock Proteins - antagonists & inhibitors | Male | Antineoplastic Agents - therapeutic use | Receptors, Glucocorticoid - metabolism | Prostatic Neoplasms, Castration-Resistant - drug therapy | Androgen Receptor Antagonists - pharmacology | Prostatic Neoplasms, Castration-Resistant - pathology | Prostate - pathology | Proteolysis - drug effects | Signal Transduction - drug effects | Protein Stability - drug effects | Treatment Failure | Prostate - drug effects | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Drug Resistance, Neoplasm - drug effects | Proteins | Care and treatment | Prostate cancer | Health aspects | Cancer | Therapy | Stability | Glucocorticoids | Therapeutic applications | Pathogenesis | Heat shock proteins | Chaperones | Carcinogenesis | Signaling | Carcinogens | Androgens | Molecular modelling | Castration | Evolution | Prostate | Heat shock | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2007, Volume 13, Issue 22, pp. 6579 - 6584
Purpose: The epidermal growth factor receptor (EGFR) is a protein involved in the tumor progression of many cancer types and is an important therapeutic...
Immunohistochemistry | Gene amplification | Targeted therapy | EGFR | Genitourinary cancers: prostate | CELL LUNG-CANCER | ONCOLOGY | CARCINOMAS | IN-SITU-HYBRIDIZATION | MICROARRAYS | MUTATIONS | GEFITINIB SENSITIVITY | ANDROGEN-INDEPENDENCE | EXPRESSION | PROGRESSION | Prostatic Neoplasms - pathology | Receptor, Epidermal Growth Factor - genetics | Up-Regulation | Prognosis | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Male | Gene Dosage | Receptor, Epidermal Growth Factor - analysis | Prostatic Neoplasms - diagnosis | Receptor, Epidermal Growth Factor - metabolism | Prostatic Neoplasms - enzymology | Aged | DNA, Neoplasm - analysis | Mutation
Immunohistochemistry | Gene amplification | Targeted therapy | EGFR | Genitourinary cancers: prostate | CELL LUNG-CANCER | ONCOLOGY | CARCINOMAS | IN-SITU-HYBRIDIZATION | MICROARRAYS | MUTATIONS | GEFITINIB SENSITIVITY | ANDROGEN-INDEPENDENCE | EXPRESSION | PROGRESSION | Prostatic Neoplasms - pathology | Receptor, Epidermal Growth Factor - genetics | Up-Regulation | Prognosis | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Male | Gene Dosage | Receptor, Epidermal Growth Factor - analysis | Prostatic Neoplasms - diagnosis | Receptor, Epidermal Growth Factor - metabolism | Prostatic Neoplasms - enzymology | Aged | DNA, Neoplasm - analysis | Mutation
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2019, Volume 861, p. 172534
Cepharanthine is a biscoclaurine alkaloid extracted from that has a variety of biological activities in multiple diseases. Spinal and bulbar muscular atrophy...
Degradation | Spinal and bulbar muscular atrophy | Cepharanthine hydrochloride | Polyglutamine | Autophagy | Androgen receptor | SHOCK | DISEASE | PHARMACOLOGY & PHARMACY | CANCER
Degradation | Spinal and bulbar muscular atrophy | Cepharanthine hydrochloride | Polyglutamine | Autophagy | Androgen receptor | SHOCK | DISEASE | PHARMACOLOGY & PHARMACY | CANCER
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 05/2007, Volume 27, Issue 19, pp. 5115 - 5126
Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine tract within the androgen receptor...
Protein degradation | CHIP | Polyglutamine | SBMA | Androgen receptor | Transgenic mice | LIGASE CHIP | MOLECULAR CHAPERONES | RECESSIVE BULBOSPINAL NEURONOPATHY | QUALITY-CONTROL | polyglutamine | 70-INTERACTING PROTEIN | NEUROSCIENCES | E3 LIGASE | HEAT-SHOCK PROTEINS | androgen receptor | transgenic mice | CO-CHAPERONE CHIP | CARBOXYL-TERMINUS | protein degradation | UBIQUITIN-PROTEASOME PATHWAY | Central Nervous System - metabolism | Humans | Receptors, Androgen - metabolism | Nerve Degeneration - genetics | Male | Motor Neurons - pathology | Nerve Degeneration - metabolism | Muscular Atrophy, Spinal - genetics | Female | Inclusion Bodies - metabolism | Disease Models, Animal | Genetic Predisposition to Disease - genetics | Muscular Atrophy, Spinal - metabolism | Heat-Shock Proteins - metabolism | Intranuclear Inclusion Bodies - genetics | Gene Expression Regulation - physiology | Mice, Transgenic | Mutation - genetics | Down-Regulation - genetics | Protein Folding | Motor Neurons - metabolism | Inclusion Bodies - genetics | Phenotype | Animals | Receptors, Androgen - genetics | Muscular Atrophy, Spinal - therapy | Mice | Central Nervous System - physiopathology | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-Protein Ligases - genetics | Intranuclear Inclusion Bodies - metabolism | Genetic Therapy - methods | Nerve Degeneration - therapy
Protein degradation | CHIP | Polyglutamine | SBMA | Androgen receptor | Transgenic mice | LIGASE CHIP | MOLECULAR CHAPERONES | RECESSIVE BULBOSPINAL NEURONOPATHY | QUALITY-CONTROL | polyglutamine | 70-INTERACTING PROTEIN | NEUROSCIENCES | E3 LIGASE | HEAT-SHOCK PROTEINS | androgen receptor | transgenic mice | CO-CHAPERONE CHIP | CARBOXYL-TERMINUS | protein degradation | UBIQUITIN-PROTEASOME PATHWAY | Central Nervous System - metabolism | Humans | Receptors, Androgen - metabolism | Nerve Degeneration - genetics | Male | Motor Neurons - pathology | Nerve Degeneration - metabolism | Muscular Atrophy, Spinal - genetics | Female | Inclusion Bodies - metabolism | Disease Models, Animal | Genetic Predisposition to Disease - genetics | Muscular Atrophy, Spinal - metabolism | Heat-Shock Proteins - metabolism | Intranuclear Inclusion Bodies - genetics | Gene Expression Regulation - physiology | Mice, Transgenic | Mutation - genetics | Down-Regulation - genetics | Protein Folding | Motor Neurons - metabolism | Inclusion Bodies - genetics | Phenotype | Animals | Receptors, Androgen - genetics | Muscular Atrophy, Spinal - therapy | Mice | Central Nervous System - physiopathology | Proteasome Endopeptidase Complex - metabolism | Ubiquitin-Protein Ligases - genetics | Intranuclear Inclusion Bodies - metabolism | Genetic Therapy - methods | Nerve Degeneration - therapy
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2015, Volume 290, Issue 25, pp. 15746 - 15757
Background: FK506-binding protein 51 (FKBP51) inhibits and FKBP52 stimulates transcription by various steroid receptors. Exchange of a single residue largely...
HSP90 | ACTIVE-SITE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GR-ALPHA | RELAXATION | allosteric regulation | CHEMICAL-EXCHANGE | conformational change | x-ray crystallography | GLUCOCORTICOID-RECEPTOR | nuclear magnetic resonance (NMR) | DYNAMICS | prolyl isomerase | PROGESTERONE-RECEPTOR | BINDING | ASSOCIATION | Protein Structure, Tertiary | Protein Structure, Secondary | Tacrolimus Binding Proteins - chemistry | Humans | Receptors, Androgen - metabolism | Models, Molecular | Receptors, Glucocorticoid - metabolism | Tacrolimus Binding Proteins - metabolism | Mutation, Missense | Tacrolimus Binding Proteins - genetics | Receptors, Androgen - genetics | Protein Structure, Quaternary | Receptors, Glucocorticoid - genetics | Nuclear Magnetic Resonance, Biomolecular | Receptors, Androgen - chemistry | Receptors, Glucocorticoid - chemistry | Amino Acid Substitution | MATERIALS SCIENCE | Protein Structure and Folding
HSP90 | ACTIVE-SITE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GR-ALPHA | RELAXATION | allosteric regulation | CHEMICAL-EXCHANGE | conformational change | x-ray crystallography | GLUCOCORTICOID-RECEPTOR | nuclear magnetic resonance (NMR) | DYNAMICS | prolyl isomerase | PROGESTERONE-RECEPTOR | BINDING | ASSOCIATION | Protein Structure, Tertiary | Protein Structure, Secondary | Tacrolimus Binding Proteins - chemistry | Humans | Receptors, Androgen - metabolism | Models, Molecular | Receptors, Glucocorticoid - metabolism | Tacrolimus Binding Proteins - metabolism | Mutation, Missense | Tacrolimus Binding Proteins - genetics | Receptors, Androgen - genetics | Protein Structure, Quaternary | Receptors, Glucocorticoid - genetics | Nuclear Magnetic Resonance, Biomolecular | Receptors, Androgen - chemistry | Receptors, Glucocorticoid - chemistry | Amino Acid Substitution | MATERIALS SCIENCE | Protein Structure and Folding
Journal Article
生物化学与生物物理学报:英文版, ISSN 1672-9145, 2015, Volume 47, Issue 8, pp. 571 - 580
Autophagy is a highly regulated and multistep biological process whereby cells under metabolic, proteotoxic, or other stresses remove dysfunctional organelles...
降解蛋白 | 应力消除 | 自噬作用 | 生物过程 | 受体蛋白 | 细胞代谢 | BRCA1 | 错误折叠 | Autophagy | Selective | Receptor proteins | REGULATE AUTOPHAGY | ANDROGEN RECEPTOR | autophagy | selective | PARKIN-MEDIATED MITOPHAGY | UBIQUITIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIR MOTIF | P62 | CARGO RECEPTOR | PINK1/PARKIN-MEDIATED MITOPHAGY | BIOPHYSICS | STRUCTURAL BASIS | receptor proteins | CBL FAMILY | Organelle Biogenesis | Proteins - physiology | Adaptor Proteins, Signal Transducing - physiology | Animals | Proteolysis | Sequestosome-1 Protein | Humans | Receptors, Cytoplasmic and Nuclear - physiology | Autophagy - physiology | Index Medicus
降解蛋白 | 应力消除 | 自噬作用 | 生物过程 | 受体蛋白 | 细胞代谢 | BRCA1 | 错误折叠 | Autophagy | Selective | Receptor proteins | REGULATE AUTOPHAGY | ANDROGEN RECEPTOR | autophagy | selective | PARKIN-MEDIATED MITOPHAGY | UBIQUITIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIR MOTIF | P62 | CARGO RECEPTOR | PINK1/PARKIN-MEDIATED MITOPHAGY | BIOPHYSICS | STRUCTURAL BASIS | receptor proteins | CBL FAMILY | Organelle Biogenesis | Proteins - physiology | Adaptor Proteins, Signal Transducing - physiology | Animals | Proteolysis | Sequestosome-1 Protein | Humans | Receptors, Cytoplasmic and Nuclear - physiology | Autophagy - physiology | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 03/2003, Volume 23, Issue 6, pp. 2203 - 2211
Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of the polyglutamine ( polyQ) tract within the androgen...
Protein degradation | HSP70 | Polyglutamine | SBMA | Chaperone | Transgenic mice | EXPANDED POLYGLUTAMINE | INHIBITS HUNTINGTIN AGGREGATION | MOLECULAR CHAPERONES | polyglutamine | BINDING PROTEIN | SUPPRESSION | NEUROSCIENCES | CELLULAR TOXICITY | chaperone | transgenic mice | DISEASE | N-TERMINAL HUNTINGTIN | CYTOCHROME-C RELEASE | protein degradation | Immunohistochemistry | Humans | Receptors, Androgen - metabolism | Male | Muscular Atrophy, Spinal - genetics | Cell Nucleus - metabolism | Cell Nucleus - pathology | Muscular Atrophy, Spinal - physiopathology | Disease Models, Animal | HSP70 Heat-Shock Proteins - biosynthesis | Molecular Chaperones - biosynthesis | Gene Expression | Molecular Chaperones - genetics | HSP70 Heat-Shock Proteins - genetics | Mice, Transgenic | Muscular Atrophy, Spinal - pathology | Blotting, Western | Disease Progression | Macromolecular Substances | Motor Activity - genetics | Phenotype | Animals | Receptors, Androgen - genetics | Trinucleotide Repeat Expansion - genetics | Mice | Mutation | Crosses, Genetic | ARTICLE
Protein degradation | HSP70 | Polyglutamine | SBMA | Chaperone | Transgenic mice | EXPANDED POLYGLUTAMINE | INHIBITS HUNTINGTIN AGGREGATION | MOLECULAR CHAPERONES | polyglutamine | BINDING PROTEIN | SUPPRESSION | NEUROSCIENCES | CELLULAR TOXICITY | chaperone | transgenic mice | DISEASE | N-TERMINAL HUNTINGTIN | CYTOCHROME-C RELEASE | protein degradation | Immunohistochemistry | Humans | Receptors, Androgen - metabolism | Male | Muscular Atrophy, Spinal - genetics | Cell Nucleus - metabolism | Cell Nucleus - pathology | Muscular Atrophy, Spinal - physiopathology | Disease Models, Animal | HSP70 Heat-Shock Proteins - biosynthesis | Molecular Chaperones - biosynthesis | Gene Expression | Molecular Chaperones - genetics | HSP70 Heat-Shock Proteins - genetics | Mice, Transgenic | Muscular Atrophy, Spinal - pathology | Blotting, Western | Disease Progression | Macromolecular Substances | Motor Activity - genetics | Phenotype | Animals | Receptors, Androgen - genetics | Trinucleotide Repeat Expansion - genetics | Mice | Mutation | Crosses, Genetic | ARTICLE
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 13, pp. 21501 - 21515
Both nuclear receptor interaction protein (NRIP) and DNA damage binding protein 2 (DDB2) belong to the Cullin 4 (CUL4)-DDB1 binding protein family and are...
Cribriform prostate cancer | Cul4-DDB1 | NRIP/DCAF6 | DDB2 | CELLS | DUCTAL ADENOCARCINOMA | DNA-DAMAGE | CRIBRIFORM PATTERN | BINDING-PROTEIN | OVARIAN-CANCER | CELL BIOLOGY | BREAST-CANCER | LUNG-CANCER | CUL4-DDB1 UBIQUITIN LIGASE | cribriform prostate cancer | TUMOR-SUPPRESSOR | Immunohistochemistry | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Immunoprecipitation | Humans | Receptors, Androgen - metabolism | Male | Nuclear Proteins - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | DNA-Binding Proteins - metabolism | Cullin Proteins - metabolism | Protein Stability | Adaptor Proteins, Signal Transducing - metabolism
Cribriform prostate cancer | Cul4-DDB1 | NRIP/DCAF6 | DDB2 | CELLS | DUCTAL ADENOCARCINOMA | DNA-DAMAGE | CRIBRIFORM PATTERN | BINDING-PROTEIN | OVARIAN-CANCER | CELL BIOLOGY | BREAST-CANCER | LUNG-CANCER | CUL4-DDB1 UBIQUITIN LIGASE | cribriform prostate cancer | TUMOR-SUPPRESSOR | Immunohistochemistry | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Immunoprecipitation | Humans | Receptors, Androgen - metabolism | Male | Nuclear Proteins - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | DNA-Binding Proteins - metabolism | Cullin Proteins - metabolism | Protein Stability | Adaptor Proteins, Signal Transducing - metabolism
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 10/2017, Volume 28, Issue 9, pp. 1018 - 1031
Androgen receptor (AR) expression and activity is highly linked to the development and progression of prostate cancer and is a target of therapeutic strategies...
prostate cancer cells | APOPTOSIS | DIHYDROARTEMISININ | PHOSPHORYLATION | antiproliferative signaling | ANTIMALARIAL | artemisinin | ONCOLOGY | PATHWAY | GROWTH | LNCAP CELLS | AKT-1 | PHARMACOLOGY & PHARMACY | androgen receptor degradation | CYTOTOXICITY | EXPRESSION | CYCLE | Prostatic Neoplasms - metabolism | Humans | Receptors, Androgen - metabolism | Male | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Artemisinins - pharmacology | Prostatic Neoplasms - genetics | Ubiquitination - drug effects | Transcription, Genetic | Prostate-Specific Antigen - metabolism | Phosphorylation - drug effects | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Prostatic Neoplasms - drug therapy | Prostate-Specific Antigen - genetics | Enzyme Inhibitors - pharmacology | Kallikreins - genetics | Morpholines - pharmacology | Down-Regulation - drug effects | Phosphatidylinositol 3-Kinases - genetics | Receptors, Androgen - genetics | Cell Line, Tumor | Mutation | Proteasome Endopeptidase Complex - metabolism | Kallikreins - metabolism
prostate cancer cells | APOPTOSIS | DIHYDROARTEMISININ | PHOSPHORYLATION | antiproliferative signaling | ANTIMALARIAL | artemisinin | ONCOLOGY | PATHWAY | GROWTH | LNCAP CELLS | AKT-1 | PHARMACOLOGY & PHARMACY | androgen receptor degradation | CYTOTOXICITY | EXPRESSION | CYCLE | Prostatic Neoplasms - metabolism | Humans | Receptors, Androgen - metabolism | Male | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - genetics | Artemisinins - pharmacology | Prostatic Neoplasms - genetics | Ubiquitination - drug effects | Transcription, Genetic | Prostate-Specific Antigen - metabolism | Phosphorylation - drug effects | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Prostatic Neoplasms - drug therapy | Prostate-Specific Antigen - genetics | Enzyme Inhibitors - pharmacology | Kallikreins - genetics | Morpholines - pharmacology | Down-Regulation - drug effects | Phosphatidylinositol 3-Kinases - genetics | Receptors, Androgen - genetics | Cell Line, Tumor | Mutation | Proteasome Endopeptidase Complex - metabolism | Kallikreins - metabolism
Journal Article
Metabolism, ISSN 0026-0495, 2013, Volume 62, Issue 8, pp. 1180 - 1188
Abstract Objective Premenopausal women demonstrate a distinctive gynoid body fat distribution and circulating estrogen status is associated with the...
Endocrinology & Metabolism | Caucasian | Sex steroid receptors | Body fat distribution | Estradiol | African American | VISCERAL FAT | DISEASE RISK-FACTORS | POSTMENOPAUSAL HORMONE-THERAPY | AFRICAN-AMERICAN | ER-ALPHA | BETA | BODY-FAT | REGIONAL FAT DISTRIBUTION | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | Buttocks | United States | Humans | European Continental Ancestry Group | Receptors, G-Protein-Coupled - biosynthesis | Gonadal Steroid Hormones - blood | Blotting, Western | Obesity - metabolism | Young Adult | Overweight - metabolism | Abdominal Fat - metabolism | Subcutaneous Fat - metabolism | Biopsy | Estrogen Receptor beta - biosynthesis | Lipids - blood | Adolescent | Receptors, Estrogen - biosynthesis | Adult | Female | Estrogen Receptor alpha - biosynthesis | African Continental Ancestry Group | Premenopause - metabolism | Body Composition - physiology | Women | Adipose tissues | Obesity | Menopause | Low density lipoproteins | Estrogen | Hormones | Sulfates | Cholesterol | Dehydroepiandrosterone | Androgens | Analysis | Phenols | Insulin resistance | G proteins
Endocrinology & Metabolism | Caucasian | Sex steroid receptors | Body fat distribution | Estradiol | African American | VISCERAL FAT | DISEASE RISK-FACTORS | POSTMENOPAUSAL HORMONE-THERAPY | AFRICAN-AMERICAN | ER-ALPHA | BETA | BODY-FAT | REGIONAL FAT DISTRIBUTION | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | Buttocks | United States | Humans | European Continental Ancestry Group | Receptors, G-Protein-Coupled - biosynthesis | Gonadal Steroid Hormones - blood | Blotting, Western | Obesity - metabolism | Young Adult | Overweight - metabolism | Abdominal Fat - metabolism | Subcutaneous Fat - metabolism | Biopsy | Estrogen Receptor beta - biosynthesis | Lipids - blood | Adolescent | Receptors, Estrogen - biosynthesis | Adult | Female | Estrogen Receptor alpha - biosynthesis | African Continental Ancestry Group | Premenopause - metabolism | Body Composition - physiology | Women | Adipose tissues | Obesity | Menopause | Low density lipoproteins | Estrogen | Hormones | Sulfates | Cholesterol | Dehydroepiandrosterone | Androgens | Analysis | Phenols | Insulin resistance | G proteins
Journal Article
Steroids, ISSN 0039-128X, 2009, Volume 74, Issue 13, pp. 1033 - 1039
The purpose of this study was to examine the acute effect of resistance exercise (RE) on muscle androgen receptor (AR) and glucocorticoid receptor (GR) protein...
Testosterone | Endocrine | Exercise training | Androgen receptor | Glucocorticoid receptor | ACUTE HORMONAL RESPONSES | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEAVY-RESISTANCE | BODY-COMPOSITION | SKELETAL-MUSCLE | GLUCOCORTICOID-RECEPTOR | MESSENGER-RNA | NANDROLONE DECANOATE | ENDOCRINOLOGY & METABOLISM | OLDER MEN | Humans | Receptors, Androgen - metabolism | Male | Muscle, Skeletal - metabolism | Receptors, Glucocorticoid - metabolism | Muscle, Skeletal - cytology | Resistance Training | Young Adult | Exercise | Sex Factors | Adult | Female | Testosterone - blood | Physiological aspects | Corticosteroids | Universities and colleges | Analysis
Testosterone | Endocrine | Exercise training | Androgen receptor | Glucocorticoid receptor | ACUTE HORMONAL RESPONSES | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEAVY-RESISTANCE | BODY-COMPOSITION | SKELETAL-MUSCLE | GLUCOCORTICOID-RECEPTOR | MESSENGER-RNA | NANDROLONE DECANOATE | ENDOCRINOLOGY & METABOLISM | OLDER MEN | Humans | Receptors, Androgen - metabolism | Male | Muscle, Skeletal - metabolism | Receptors, Glucocorticoid - metabolism | Muscle, Skeletal - cytology | Resistance Training | Young Adult | Exercise | Sex Factors | Adult | Female | Testosterone - blood | Physiological aspects | Corticosteroids | Universities and colleges | Analysis
Journal Article
Medicina (Lithuania), ISSN 1010-660X, 07/2018, Volume 54, Issue 3, p. 39
Background and Objective: Although triptolide was effective for prostate cancer (PCa), the mechanism is still unclear. Androgen receptor (AR) plays a large...
Calpain | Protein stability | Triptolide | Androgen receptor | PROSTATE | ACTIVATION | PHOSPHORYLATION | triptolide | protein stability | calpain | MEDICINE, GENERAL & INTERNAL | androgen receptor | AMPLIFICATION | INHIBITION | GENE | DEGRADATION | CANCER STATISTICS | EXPRESSION
Calpain | Protein stability | Triptolide | Androgen receptor | PROSTATE | ACTIVATION | PHOSPHORYLATION | triptolide | protein stability | calpain | MEDICINE, GENERAL & INTERNAL | androgen receptor | AMPLIFICATION | INHIBITION | GENE | DEGRADATION | CANCER STATISTICS | EXPRESSION
Journal Article
Journal of Trace Elements in Medicine and Biology, ISSN 0946-672X, 07/2018, Volume 48, pp. 233 - 238
Cadmium is a known carcinogen that has been implicated in prostate cancer, but how it affects prostate carcinogenesis in humans remains unclear. Evidence from...
Cadmium | Prostate cancer | Androgen receptor | Heavy metal | African American | RACE/ETHNICITY | DNA-ADDUCTS | POLYCYCLIC AROMATIC-HYDROCARBON | BIOCHEMISTRY & MOLECULAR BIOLOGY | NATIONAL-HEALTH | SMOKING | CANCER | GENE | ENDOCRINOLOGY & METABOLISM | MENTHOL CIGARETTES | EXPOSURE | Prostatic Neoplasms - metabolism | Receptors, Androgen - biosynthesis | United States | Humans | Middle Aged | African Americans | Cadmium - analysis | European Continental Ancestry Group | Male | Prostate-specific antigen | Zinc in the body | Development and progression | Mass spectrometry | Tumors | Index Medicus | heavy metal | cadmium | prostate cancer | androgen receptor
Cadmium | Prostate cancer | Androgen receptor | Heavy metal | African American | RACE/ETHNICITY | DNA-ADDUCTS | POLYCYCLIC AROMATIC-HYDROCARBON | BIOCHEMISTRY & MOLECULAR BIOLOGY | NATIONAL-HEALTH | SMOKING | CANCER | GENE | ENDOCRINOLOGY & METABOLISM | MENTHOL CIGARETTES | EXPOSURE | Prostatic Neoplasms - metabolism | Receptors, Androgen - biosynthesis | United States | Humans | Middle Aged | African Americans | Cadmium - analysis | European Continental Ancestry Group | Male | Prostate-specific antigen | Zinc in the body | Development and progression | Mass spectrometry | Tumors | Index Medicus | heavy metal | cadmium | prostate cancer | androgen receptor
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 2014, Volume 12, Issue 1, p. 313
Background: Many current therapies for metastatic castration-resistant prostate cancer (mCRPC) are aimed at AR signaling; however, resistance to these...
Castration-resistant prostate cancer | Prostate neoplasms | Circulating tumor cells | Androgen receptor | LEUKEMIA GROUP-B | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | BIOMARKER | VARIANTS | PERIPHERAL-BLOOD | THERAPY | AMPLIFICATION | GENE | CARCINOMA | PROGRESSION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Humans | Middle Aged | Receptors, Androgen - metabolism | Male | Feasibility Studies | Orchiectomy | Neoplasm Metastasis | Flow Cytometry | Neoplastic Cells, Circulating | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Medicine, Experimental | Medical research | Care and treatment | Prostate cancer | Flow cytometry | Laboratories | Mortality | Colleges & universities | Metastasis | Cancer therapies | Patients | Blood | Proteins | Androgens | Microscopy | Biopsy | Medical prognosis | Protein expression | Deoxyribonucleic acid--DNA | Questioning
Castration-resistant prostate cancer | Prostate neoplasms | Circulating tumor cells | Androgen receptor | LEUKEMIA GROUP-B | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | BIOMARKER | VARIANTS | PERIPHERAL-BLOOD | THERAPY | AMPLIFICATION | GENE | CARCINOMA | PROGRESSION | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Humans | Middle Aged | Receptors, Androgen - metabolism | Male | Feasibility Studies | Orchiectomy | Neoplasm Metastasis | Flow Cytometry | Neoplastic Cells, Circulating | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Medicine, Experimental | Medical research | Care and treatment | Prostate cancer | Flow cytometry | Laboratories | Mortality | Colleges & universities | Metastasis | Cancer therapies | Patients | Blood | Proteins | Androgens | Microscopy | Biopsy | Medical prognosis | Protein expression | Deoxyribonucleic acid--DNA | Questioning
Journal Article